SCHEMBL6970957

SCHEMBL6970957

COC(=O)NC(=O)C(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.40
PKM P14618 1/20 0.40
PTK2B Q14289 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.37
KDM4E B2RXH2 3/20 0.37
LMNA P02545 3/20 0.37
ALOX12 P18054 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.34
ALDH1A1 P00352 4/20 0.33
HSD17B10 Q99714 2/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
F2 P00734 1/20 0.32
MAPT P10636 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
DGAT1 O75907 1/20 0.32
RECQL P46063 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL29261876 0.91 CYP1A2 (0.35) CYP1A2PKMPTK2BL3MBTL1KDM4E
SCHEMBL30083950 0.79 TDP1 (0.39) CYP1A2PKMPTK2BSMN1; SMN2GAA
SCHEMBL5690876 0.78 CYP1A2 (0.48) CYP1A2PKMPTK2BL3MBTL1KDM4E
SCHEMBL4119686 0.76 L3MBTL1 (0.46) L3MBTL1LMNASMN1; SMN2ALDH1A1HSD17B10
SCHEMBL14612345 0.75 RIPK1 (0.39) L3MBTL1LMNAGAAHTTNPSR1
SCHEMBL10724669 0.75 MGAM (0.42) CYP1A2L3MBTL1LMNASMN1; SMN2GAA
SCHEMBL862169 0.75
SCHEMBL16029151 0.74 HSD17B10 (0.42) CYP1A2PKMPTK2BL3MBTL1ALDH1A1
SCHEMBL12572603 0.73 CYP1A2 (0.44) CYP1A2PKMPTK2BL3MBTL1KDM4E
SCHEMBL6971165 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117956991-A N, N-dimethyltryptamine and related hallucinogens and uses thereof 人类生物科学股份有限公司 2024-04-30 CN disclosed
US-20080293674-A1 Azinyl Imidazoazine and Azinyl Carboxamide BAYER CROPSCIENCE AG (DE) 2008-11-27 US disclosed
US-7183027-B2 Image forming method FUJI XEROX CO., LTD. (JP) 2007-02-27 US disclosed
EP-1329160-A2 4-ACYLAMINOPYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-07-23 EP disclosed
CN-1076439-A The new derivative of 3-hydroxyanthranilic acid, Preparation Method And The Use ASTRA AB (SE) 1993-09-22 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293674-A1 Azinyl Imidazoazine and Azinyl Carboxamide AZI2, NISCH, ZYX CYP1A2 207/4885PKM 3890/4885PTK2B 4172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.